Works matching IS 10837159 AND DT 2013 AND VI 18 AND IP 4


Results: 26
    1
    2
    3
    4

    Multicenter Phase II Study of Tivozanib (AV-951) and Everolimus (RAD001) for Patients With Refractory, Metastatic Colorectal Cancer.

    Published in:
    Oncologist, 2013, v. 18, n. 4, p. 377, doi. 10.1634/theoncologist.2012-0378
    By:
    • Wolpin, Brian M.;
    • Ng, Kimmie;
    • Zhu, Andrew X.;
    • Abrams, Thomas;
    • Enzinger, Peter C.;
    • McCleary, Nadine J.;
    • Schrag, Deborah;
    • Kwak, Eunice L.;
    • Allen, Jill N.;
    • Bhargava, Pankaj;
    • Chan, Jennifer A.;
    • Goessling, Wolfram;
    • Blaszkowsky, Lawrence S.;
    • Supko, Jeffrey G.;
    • Elliot, Meaghan;
    • Sato, Kaori;
    • Regan, Eileen;
    • Meyerhardt, Jeffrey A.;
    • Fuchs, Charles S.
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12

    In Reply.

    Published in:
    2013
    By:
    • Rosen, Alyx C.;
    • Gavrilovic, Igor T.;
    • Balagula, Yevgeniy;
    • Ramaswamy, Vijay;
    • Dickler, Maura N.;
    • Dunkel, Ira J.;
    • Lacouture, Mario E.
    Publication type:
    Letter
    13

    A Phase II Randomized Dose Escalation Trial of Sorafenib in Patients With Advanced Hepatocellular Carcinoma.

    Published in:
    Oncologist, 2013, v. 18, n. 4, p. 379, doi. 10.1634/theoncologist.2012-0221
    By:
    • Rimassa, Lorenza;
    • Pressiani, Tiziana;
    • Boni, Corrado;
    • Carnaghi, Carlo;
    • Rota Caremoli, Elena;
    • Fagiuoli, Stefano;
    • Foa, Paolo;
    • Salvagni, Stefania;
    • Cortesi, Enrico;
    • Chiara Tronconi, Maria;
    • Personeni, Nicola;
    • Bozzarelli, Silvia;
    • Chiara Banzi, Maria;
    • Fanello, Silvia;
    • Romano Lutman, Fabio;
    • Giordano, Laura;
    • Santoro, Armando
    Publication type:
    Article
    14
    15

    Toxicity of Bevacizumab in Combination with Chemotherapy in Older Patients.

    Published in:
    Oncologist, 2013, v. 18, n. 4, p. 408, doi. 10.1634/theoncologist.2012-0351
    By:
    • Mohile, Supriya G.;
    • Hardt, Molly;
    • Tew, William;
    • Owusu, Cynthia;
    • Klepin, Heidi;
    • Gross, Cary;
    • Gajra, Ajeet;
    • Lichtman, Stuart M.;
    • Feng, Tao;
    • Togawa, Kayo;
    • Ramani, Rupal;
    • Katheria, Vani;
    • Hansen, Kurt;
    • Hurria, Arti
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23

    A Phase II Study of Amrubicin as a Third-Line or Fourth-Line Chemotherapy for Patients With Non-Small Cell Lung Cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0901.

    Published in:
    Oncologist, 2013, v. 18, n. 4, p. 439, doi. 10.1634/theoncologist.2012-0308
    By:
    • Harada, Toshiyuki;
    • Oizumi, Satoshi;
    • Ito, Kenichiro;
    • Takamura, Kei;
    • Kikuchi, Eiki;
    • Kuda, Tomoya;
    • Sugawara, Shunichi;
    • Suzuki, Aya;
    • Maemondo, Makoto;
    • Fujita, Yuka;
    • Kinoshita, Ichiro;
    • Inoue, Akira;
    • Hommura, Fumihiro;
    • Katsuura, Yutaka;
    • Dosaka‐Akita, Hirotoshi;
    • Isobe, Hiroshi;
    • Nishimura, Masaharu
    Publication type:
    Article
    24
    25
    26